Effects of no-flow ischemia (NFI) and reperfusion (RPF) on myocardial extraction and retention of technetium-99m hexakis(2-methoxyisobutylisonitrile) (sestamibi) and thallium-201 were investigated in 12 isolated, blood-perfused rabbit hearts with isotope dilution studies at constant coronary perfusion. After a control injection of tracers, NFI was induced for 30-60 minutes. After coronary reflow, repeat tracer injections were given at early RPF (5-15 minutes of RPF) and late RPF (40-60 minutes of RPF). After NFI-RPF, maximal fractional extraction and capillary permeability-surface area product increased for sestamibi (from +39%o to 69o) and decreased for thallium (from -14% to -68%). Net extraction was 33% lower for sestamibi than for thallium at control, 13% lower at early RPF, and 90% higher than thallium at late RPF. Interstitial-myocyte exchange estimates were always higher for sestamibi than for thallium and increased for both with NFI-RPF (sestamibi, from 57.4 to 122.4 ml/min/g; thallium, from 3.1 to 22.3 ml/min/g). Intramyocyte volumes of distribution were higher for sestamibi than for thallium (>200% at control, 800-1,000% with RPF), and NFI-RPF had opposite effects on the two tracers (late RPF vs. control: +28% for sestamibi, -50%o for thallium). Our Accurate interpretation of myocardial perfusion images would benefit from a thorough understanding of the capillary-tissue exchange process of the imaging tracer and the factors that affect this exchange. Our previous studies7 demonstrated that sestamibi, like thallium, was taken up by the myocardium in proportion to flow but that peak sestamibi extraction and capillary permeability were significantly less than for thallium. However, myocyte permeability and volume of distribution was higher for sestamibi than for thallium.7 Little is known about the effects of altered cell metabolism on sestamibi uptake in the heart. Cell culture studies8 have revealed that myocyte uptake of sestamibi and thallium are inhibited during hypoxia and that thallium is more affected than sestamibi. In other reports,9 thallium uptake by the myocardium was independent of tissue viability, which seems to contradict cell culture evidence that a ouabain-sensitive mechanism (i.e., Na+, K+-ATPase) contributes about 60% of thallium uptake.'0"11
T echnetium-99m (99mTc)-labeled agents have been proposed as alternatives to thallium-201 for noninvasive assessment of myocardial perfusion because of lower cost, better clinical availability, improved photon statistics, and superior Anger camera-imaging properties.1-4 One group of promising agents, the isonitriles, has provided clinical perfusion images that are comparable with those from thallium. 3, 5 One of the isonitrile compounds, [9'Tc] hexakis (2- methoxyisobutylisonitrile), which is generically known as sestamibi (E.I. du Pont de Nemours, North Billerica, Massachusetts), has demonstrated strong potential in preliminary studies for use in myocardial imaging after intravenous injection. 6 Accurate interpretation of myocardial perfusion images would benefit from a thorough understanding of the capillary-tissue exchange process of the imaging tracer and the factors that affect this exchange. Our previous studies7 demonstrated that sestamibi, like thallium, was taken up by the myocardium in proportion to flow but that peak sestamibi extraction and capillary permeability were significantly less than for thallium. However, myocyte permeability and volume of distribution was higher for sestamibi than for thallium. 7 Little is known about the effects of altered cell metabolism on sestamibi uptake in the heart. Cell culture studies8 have revealed that myocyte uptake of sestamibi and thallium are inhibited during hypoxia and that thallium is more affected than sestamibi. In other reports,9 thallium uptake by the myocardium was independent of tissue viability, which seems to contradict cell culture evidence that a ouabain-sensitive mechanism (i.e., Na+, K+-ATPase) contributes about 60% of thallium uptake.'0"11
To critically evaluate effects of myocardial metabolic function on the transport of sestamibi and thallium, an isolated heart model was used to deter-mine the effects of no-flow ischemia (NFI) and reperfusion (RPF) on myocardial capillary-tissue exchange of these two tracers. Improved knowledge of transport and retention of these tracers after RPF will assist clinical scientists in image interpretation and help basic scientists understand alterations in myocardial physiology induced by NFI-RPF injury.
Materials and Methods

Experimental Preparation
Surgery and perfusion. Isolated, isovolumetrically contracting rabbit hearts were perfused by established methods.7"12"13 Briefly, male New Zealand White rabbits (1.5-2.5 kg) were heparinized (600 IU/kg i.v.) and anesthetized (40 mg/kg i.v. sodium pentobarbital). Hearts were quickly removed, mounted on a perfusion apparatus, and retrogradely perfused via the aorta with whole blood obtained from a second heparinized and anesthetized rabbit; a constant flow pump that was adjusted to produce a mean aortic pressure of 100-125 mm Hg was used. A pacing catheter and temperature probe were placed in the right ventricle through the right atrium, and a vinyl catheter was placed in the right ventricle through the pulmonary artery to determine coronary flow rates and to collect coronary sinus drainage for indicator dilution experiments. In the left ventricle, thebesian vein flow and aortic valve leakage were drained by a plastic tube inserted in the left ventricular apex. Left ventricular pressure and its first derivative were constantly monitored with a salinefilled balloon inserted into the left ventricle via the left atrium. The heart was placed in a water-jacketed chamber filled with saline and maintained at 37°± 10 C and was paced to at least 160 beats/min.
The blood perfusate was oxygenated with 3% CO2-97% air as it passed through a membrane oxygenator, and blood gas measurements were collected every 30- Isotope injection and collection. The isotope cocktail was thoroughly mixed, and a 0.3-ml bolus was quickly loaded into an injection loop that ran parallel to and joined with the aortic inflow with three-way valves. The cocktail was injected by turning the three-way valves so that the bolus was as homogeneously distributed as possible to both coronary arteries. Collection of the coronary venous effluent into preweighed plastic tubes (1-3 seconds each, 3-4 minutes total) was timed so that each tube contained approximately 0.2 ml. After weighing each tube, activities in the samples and in a 0.1-ml aliquot of injectate were determined in a gamma well-counter. Appropriate corrections for energy crossover, background, and decay were made for each isotope, and activities were expressed as counts per minutes per gram. Tissue water fraction of the left ventricular free wall was also determined.12
Experimental Protocol
After temperature, coronary flow and pressure, and ventricular pressure stabilized (approximately 15 minutes after beginning the perfusion), the first isotope-dilution study, the control injection, was conducted. After this initial injection, global NFI was induced by stopping the perfusion pump for 30 To estimate turnover time of sestamibi and thallium in the myocardium, r (in minutes) was calculated from the equation: r=(V'p+V'isf)/PSC, using V'p,, V'ijf, and PSc estimated from the modeling analysis.
Statistical Analysis
Data are expressed as the mean+SEM. Comparison of differences among serial injections within each heart and between sestamibi and thallium within each injection were performed by paired statistical analysis (i.e., repeated-measure analysis of variance or paired t tests).25,26 Differences were considered significant at p<0.05. Table 1 contains the hemodynamic parameters for control, early RPF, and late RPF experimental injections. Paired statistical analysis revealed that heart rate and peak left ventricular systolic pressure were significantly less at early RPF and at late RPF relative to control; aortic pressure (i.e., perfusion pressure) was significantly lower at early RPF but returned to control values at late RPF. Although left ventricular end-diastolic pressure and the pressure development and relaxation rates were not significantly depressed at early RPF, they were significantly differences between sestamibi and thallium were not constant among the injections (sestamibi was 74% less than thallium at control, 69% less at early RPF, and 46% less at late RPF). Due to the constant flow model, sestamibi PScap estimates increased relative to thallium for the same reasons noted above in the Emax determinations. Another approximation of capillary permeability-surface area product, PSc, was estimated from the modeling analysis in Figure 3 and is discussed with the other modeled parameters.
Results
Hemodynamic Measurements
Net Extraction
Enet values for sestamibi and thallium appear in Figure 2 . Compared with paired thallium values, sestamibi Enet was significantly lower at control, similar to thallium at early RPF, and significantly higher than thallium at late RPF. The average Enet for sestamibi was not significantly changed at early RPF relative to control but was significantly higher at late RPF than both control and early RPF estimates. In contrast, thallium Enet was significantly lower at early RPF compared with control and still lower at late RPF compared with control and early RPF estimates.
Model Estimates
Estimates for PSc, V'iSf, PSp., and V'p, from modeling analysis appear in Figure 3 . Overall, PSc for sestamibi was 71% lower than corresponding thallium estimates and averaged 82%, 77%, and 49% less than thallium at control, early RPF, and late RPF, respectively. The trend for PSc was similar to PS,p estimates.
As already noted, sestamibi and thallium values were most diverse at control and became progressively less different at early and late RPF because thallium values declined as sestamibi estimates increased.
However, the control and early RPF Mean transit times. An increase in mean transit time at constant flow is a strong indication of increased capillary permeability, which would allow escape of tracer into tissue and increase tissue residence time. In present studies, mean transit times for albumin were unchanged from control at early RPF but were prolonged by 10% at late RPF. Increased endothelial permeability for albumin is a consistent observation after NFI-RPF,2731-33 and prolonged albumin mean transit times can persist in myocardium that has resumed normal function after ischemia.28 Because sestamibi exchange is probably limited primarily from its molecular size7'34 and because the changes in mean transit times were similar for sestamibi and albumin, it appears that the NFI-RPF model used in these studies induced capillary damage similar to other models.27'32 '33 Interstitial volume. Endothelial cell swelling and tissue edema are early manifestations of myocardial ischemia-reperfusion injury.28.32 In the present study, interstitial volume (V'i,f) estimated from modeling EDTA dilution curves (Figure 3) Residual EDTA (i.e., 58Co activity remaining in heart tissue) would be expected to increase if significant amounts of EDTA entered parenchymal cells. In this study, 58Co activity, determined in tissue samples immediately after the late RPF injection, accounted for less than 0.01% of injected activity, which was similar to hearts in our other studies that received a single control injection (data not shown).
The tissue water fraction in the present study (0.76+0.007) might seem low compared with previous reports,7"12'36 particularly in view of the dramatic increases in V'iSf estimates described above. However, V'iSf is a very small fraction of total tissue water, and the observed increase in ViSf without an observed increase in tissue water suggests a redistribution of water from the parenchymal cells to the interstitium. Differences between the present and previous studies might also be attributed to differences in models and, more likely, to experimental treatments.
A potential source of error in the modeling analysis with the NFI-RPF model is the choice of intravascular reference. The use of albumin as intravascular reference is a standard one, but the assumption that albumin is confined to the vascular space (i.e., its PS, is zero) after NFI-RPF may not be correct.
Microvascular permeability to albumin increases after ischemic injury,27 and the mean transit times were longer for albumin in the present study (Table   2 ). However, "'In activity remaining in hearts, which provides an appraisal of the amount of albumin remaining in the myocardium, was no different (actually slightly lower) than in hearts that received a single control injection (other studies, data not shown). In addition, a significant escape of albumin from the vasculature during indicator dilution studies would depress the height of the reference h(t) curve, thereby underestimating capillary-tissue exchange (Emax, PScap, and Enet). This may account, in part, for the observed decrease in these values for thallium but could not explain the increases observed for sestamibi. Therefore, we do not believe that escape of albumin from the vasculature significantly contributed toward errors in modeling during the time frame of present studies.
Alterations in hemodynamic parameters, albumin mean transit times, and interstitial volume estimates were observed while coronary perfusion rates were kept constant. Therefore, changes in capillary-tissue exchange parameters and modeled estimates for sestamibi and thallium observed in the present study are probably a result of alterations in structure, metabolism, or chemical milieu of the cardiac tissue that have been induced by NFI-RPF injury.
Transcapillary Exchange
The transcapillary exchange parameters, which include Emax and capillary permeability-surface area products (PScap and PSC), estimate exchange between capillary and interstitial regions. In the present study, sestamibi capillary-tissue exchange was clearly much less than thallium, which has been attributed to different transport mechanisms, lipophilicity, and molecular size.2,7 Transcapillary exchange and mean transit times for sestamibi increased at late RPF, which is consistent with an increase in the molecularsize permeability for capillary tissue exchange during reflow. As endothelium is damaged from NFI-RPF, larger molecules such as sestamibi can escape from the vascular region more easily, increasing transcapillary exchange rates and mean transit times.
Two estimates of capillary permeability were calculated in this study. PSCap, the Crone17 estimate of permeability-surface area product, is dominated by the perfusion rate (flow) and peak extraction, whereas PSc is a flow-independent calculation that is consistently higher than Thus, it is clear that the transcapillary exchange of sestamibi increased after NFI-RPF, whereas that of thallium decreased.
Differences in mean transit time (Table 2 ) between sestamibi and thallium emphasize their dissimilarities in extraction and retention. An increased mean transit time for sestamibi (in parallel with mean transit time for albumin), along with a progressive increase in its Emax (Figure 1) , implies that the molecular size is an important determinant in sestamibi exchange between capillary and tissue. A decrease in mean transit time at constant flow, such as that observed for thallium (Table 2) , implies reduced tissue residence time from impaired capillary-tissue exchange and/or increased clearance of tracer from tissue.
At control, differences between sestamibi and thallium in estimated Enet ( Figure 2) were not as great as would be predicted from their differences in Emax, PSeap, or PSc. The significantly lower capillary-tissue exchange of sestamibi compared with thallium is partially offset by differences in cellular volumes of distribution (see below), which result in a longer period of Enet for sestamibi as well as a reduction in tracer back-diffusion. Because transcapillary exchange and cellular retention increased for sestamibi and decreased for thallium (Figure 1 ), Enet for sestamibi relative to thallium continued to increase and was greater than thallium at late RPF.
Although our data suggest enhanced sestamibi transcapillary exchange after coronary reflow, others have reported no significant changes in sestamibi uptake as related to microspheres in the intact canine model.37 However, sestamibi was administered 48 hours after reflow, which suggests that our initial 1-hour observations may not persist. Other preliminary reports38 show relative overestimation of segmental perfusion by sestamibi as compared with thallium in patients after thrombolytic therapy during an acute myocardial infarction. Overall, this suggests the possibility of a transient change in sestamibi transport and retention after reestablishing coronary perfusion.
Although our data suggest sestamibi transcapillary transport is enhanced after coronary reflow, others37 have reported no significant changes in sestamibi uptake relative to microsphere flows in the intact canine model. However, sestamibi was administered 48 hours after reflow in these studies, which suggests that our observations in early RPF (.l hour) may not persist. The temporal development and persistence of changes in the exchange of sestamibi and thallium clearly require more detailed study before conclusive arguments can be made.
Parenchymal Cell Estimates
Parameters for tracer exchange with the parenchymal cell (i.e., the myocyte) in the distributive model including PSpc, estimating tracer flux from interstitium to myocyte, and V'pc estimating the apparent volume of distribution of tracer within the myocyte. The present estimates of these parameters are similar to those in our previous report. 7 Larger PSpC values indicate a higher diffusive capacity across the sarcolemma membrane that can result from increased barrier permeability, expanded exchangeable surface area, or both. Exchangeable surface area is assumed to be identical for tracers concurrently injected and analyzed; therefore, differences in PSpC are most likely due to differences in permeabilities.
PSpC was clearly higher for sestamibi than thallium, revealing different transport or exchange mechanisms, and NFI-RPF induced large increases for both sestamibi and thallium.
Decreased V'pc can be interpreted as a depressed ability of the cell to sequester tracer, which can result from a reduced number of binding interactions, a lower binding affinity, or a combination of the two.
V'pc was relatively unchanged after NFI-RPF for sestamibi in these studies, which compared with a progressive decline in V'pc for thallium. Thus, sestamibi and thallium probably do not interact at the same or similar myocyte binding sites, and the structure or cellular component that interacts with sestamibi is less sensitive to NFI-RPF injury than that for thallium. Although the intracellular site(s) responsible for sestamibi and thallium binding has not been clearly identified, sestamibi has been reported to be less sensitive to hypoxic conditions in cell culture. 8 The r calculation (see "Materials and Methods") relates apparent volumes of distribution to capillary exchange rates, thereby providing an estimate of myocardial tracer turnover time. Although this calculation is not a t1/2 value, it provides an estimate of average tissue retention time after the tracer has exited the vascular region7 and is useful to relate differences among tracers or treatments. For example, comparing r between sestamibi and thallium reveals a much slower turnover time for sestamibi than thallium (31 vs. 2, overall) and a difference in sensitivity to NFI-RPF (lower for sestamibi, constant for thallium). This observation suggests that, although sestamibi has enhanced extraction in reperfused myocardial tissue, it will have a faster turnover time than at control or relatively early RPF times.
Implications
A general increase in the exchange and retention of sestamibi after NFI-RPF implies that the potential exists for some overestimation in clinical images by sestamibi of perfusion rates in ischemic, reperfused myocardium. In contrast, thallium myocardial exchange and retention seem depressed after NFI-RPF, suggesting that myocardial perfusion would be underestimated by thallium during RPF of infarcted myocardium. These observations do not establish a precise timetable, but ischemic myocardium during relatively early RPF clearly has altered sestamibi and thallium exchange and retention characteristics. This should be considered when interpreting imaging studies with these agents in appropriate clinical situations. For instance, it may be possible that coronary RPF in infarcted myocardial regions may appear to have enhanced sestamibi uptake that may be incorrectly interpreted as increased regional flow. Preliminary clinical reports38 have indicated that sestamibi overestimated myocardial perfusion in 15% of all segments studied and in 16% of the segments that had improved perfusion after thrombolytic therapy. Therefore, the results observed in the present study may have important clinical implications, and additional, critical evaluations of the development and persistence of exchange and retention alterations will be required.
The change in transport characteristics for both thallium and sestamibi in the present study cannot be interpreted as a viability marker on the basis of these data. Although 30-60 minutes of NFI predictably causes necrosis,'6 our observations pertain only to transport determinations, and no independent or direct evaluation of tissue viability was performed.
These data strongly suggest that sestamibi and thallium transport are accomplished by different mechanisms and that both are somewhat affected by the status of cellular function associated with coronary reflow. Alternative scientific approaches will be helpful to elucidate the mechanistic changes in capillary-tissue exchange that occur for sestamibi and thallium during coronary RPF.
